Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

CARPROFEN TABLETS

Active

SPE2DP-26-T-3788Federal

Response Deadline06/17/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the procurement of Carprofen Tablets under the solicitation number SPE2DP-26-T-3788, issued by the Defense Logistics Agency of the Department of Defense. The solicitation was posted on June 11, 2026, with a response deadline set for June 17, 2026. This purchase request is for a quantity of one unit associated with the National Stock Number 6509-01-487-4464. This is a federal solicitation without a specified type of set-aside or NAICS code, indicating an open opportunity for interested vendors. The contract is managed through the Defense Logistics Agency, and specific location details for office address and place of performance are not provided. Additional contract information and response submissions are accessed via the designated government procurement portal.

General Info

Procurement of Carprofen Tablets, DLA solicitation SPE2DP-26-T-3788, deadline June 17, 2026.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation

PostedJun 11

Solicitation

Response DeadlineJun 17

Submission deadline

Response Deadline

06/17/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUS

Organization / Agency

Department Of Defense → Defense Logistics Agency

Office AddressUS

ContactsNo contact information available

Full Description

Show more

CARPROFEN TABLETS NSN/Part Number: 6509-01-487-4464 Purchase Request: 7017078636QTY: 1

Similar Contracts

ANALGESIC GEL, TOPICThe contract involves the procurement of topical analgesic gel identified by NSN 6505-01-658-7643, with a quantity of one unit requested under purchase request number 7017120837. This solicitation, numbered SPE2DP-26-T-3782, was posted on June 11, 2026, with a response deadline set for June 17, 2026. The solicitation is issued by the Defense Logistics Agency, which operates under the Department of Defense. The contract is a federal solicitation with no specified set-aside type or NAICS code provided. The place of performance and office address details are not explicitly stated, and no specific point of contact information is included in the contract data. The procurement is expected to support federal needs, particularly those managed by defense logistics, emphasizing timely response and adherence to the solicitation timeline.

Defense Logistics Agency

POSTED

about 22 hours ago

DEADLINE

ACAN Autoinjector atropine and pralidoxime chlorideThe contract involves a public notice issued by the Department of Public Works and Government Services under the Government of Canada for the procurement of dual-chamber autoinjectors containing atropine and pralidoxime chloride. This Advanced Contract Award Notice (ACAN) signals the government's intention to award the contract to a pre-identified supplier unless other interested suppliers submit a statement of capabilities meeting the specified requirements by the deadline. The ACAN allows suppliers to express interest and compete, ensuring an open and transparent procurement process. The solicitation, titled "ACAN Autoinjector atropine and pralidoxime chloride," was posted on June 11, 2026, with responses due by June 29, 2026. The procurement applies to delivery within Canada and the United Kingdom. Interested parties can contact the designated contracting authority, Anja Ramenason, for further details. If no qualified submissions are received by the closing date, the contract will be awarded to the pre-identified supplier in accordance with the terms outlined in the advanced notice. Further information and documents are accessible through the official Canada Buys platform.

Department of Public Works and Government Services

POSTED

DEADLINE

6505--762-26-3-040-2307 -Tucson CMOP PROPRANOLOL -(VA-26-00068676)The Department of Veterans Affairs, through its Network Contracting Office 15 and CMOP Division, plans to solicit quotes for the procurement of three pharmaceuticals to be delivered to the Ladson (Charleston) CMOP and Tucson CMOP locations. This solicitation, identified as RFQ 36C77026Q0147, is designated as a total small business set-aside under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The estimated issue date for the solicitation is June 11, 2026, with responses due by June 18, 2026. All qualified small business vendors are encouraged to submit concise quotations in response to this requirement. Vendors must provide a valid and unexpired state wholesale distributor license demonstrating compliance with the Drug Supply Chain Security Act along with their submission, or they will be deemed non-compliant. Responses must include a signed SF1449 solicitation cover page, a price schedule in Excel format specifying the place of manufacture, the state wholesale distributor license, and a completed Buy American Act certificate. All submissions are to be sent via email to the designated contracting specialists, with contact information provided for questions. Offerors are responsible for monitoring any amendments posted on SAM.gov regarding this solicitation. The effort supports the Department of Veterans Affairs’ commitment to sourcing pharmaceuticals through small businesses while ensuring regulatory compliance and timely delivery.

National Cmop Office (36C770)

POSTED

DEADLINE

Gene-Edited iPSC Line DevelopmentThis contract involves the application of CRISPR-Cas12a gene editing technology to induce specific mutations in induced pluripotent stem cell (iPSC) lines that are linked to neurodegenerative diseases, including Alzheimer’s and Parkinson’s. The objective is to develop gene-edited iPSC lines that can be used for further research into these conditions. The work is to be performed in Bar Harbor, and the contract falls under the subcontract category with a NAICS code of 325412, which relates to pharmaceutical preparation manufacturing. The contract is facilitated by the National Institutes of Health under the Department of Health and Human Services, with a posting date of June 11, 2026. Interested parties must submit their responses by June 23, 2026, at 3:00 PM. Although there is no specified set-aside designation or organizational type for bidders, the nature of this highly specialized contract suggests a focus on advanced biomedical research institutions or companies with expertise in gene-editing technologies and stem cell biology.

National Institutes Of Health Olao

POSTED

DEADLINE

iPSC Expansion & Quality Control (QC)The contract involves the expansion of gene-edited induced pluripotent stem cell (iPSC) lines along with conducting standardized quality control testing to ensure their integrity and suitability for further use. Key quality control measures include assessments of pluripotency, karyotyping to detect chromosomal abnormalities, and contamination screening to confirm the absence of microbial presence. The work will be performed at a site located in Bar Harbor, with a specified deadline for responses set for June 23, 2026. This subcontract is issued by the National Institutes of Health under the Department of Health and Human Services. It falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The contract aims to support rigorous quality standards for gene-edited iPSC lines, critical for downstream research and therapeutic applications. While no specific set-aside or particular organization type was indicated, the contract ensures standardized procedures conducive to reproducibility and reliability in stem cell research.

National Institutes Of Health Olao

POSTED

DEADLINE